Hospital facility prices. What the hospital charges for the
facility side of care — the surgeon’s and anesthesiologist’s
fees are billed separately and are not included.
How we scope prices →
HANK Price Transparency. (n.d.).
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC (OTHER MS-DRG 837) by State.
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved , from http://ppman.hank.ai/transparency/procedure/MS-DRG 837/by-state?code_type=OTHER
MLA (9th ed.)
“CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC (OTHER MS-DRG 837) by State.” HANK Price Transparency,
http://ppman.hank.ai/transparency/procedure/MS-DRG 837/by-state?code_type=OTHER. Accessed
.
Chicago (notes-bibliography)
“CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC (OTHER MS-DRG 837) by State,” HANK Price Transparency,
accessed ,
http://ppman.hank.ai/transparency/procedure/MS-DRG 837/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology.
OTHER · across United States
MS-DRG 837 — Chemotherapy With Acute Leukemia As Secondary Diagnosis Or With High Dose Chemotherapy Agent With Mcc
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).